Description
Duracef 200 mg Capsule contains Cefixime, a third-generation cephalosporin antibiotic produced by Navana Pharmaceuticals Ltd. It is used to treat a variety of bacterial infections, including:
-
Uncomplicated urinary tract infections caused by E. coli and Proteus mirabilis
-
Otitis media caused by Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pyogenes
-
Pharyngitis and tonsillitis caused by Streptococcus pyogenes
-
Acute bronchitis and acute exacerbations of chronic bronchitis caused by Streptococcus pneumoniae and Haemophilus influenzae
-
Uncomplicated gonorrhea (cervical/urethral) caused by Neisseria gonorrhoeae
-
Typhoid fever (as part of combination therapy)
Cefixime works by inhibiting the synthesis of bacterial cell walls, leading to the death of the bacteria. It is effective against a broad spectrum of gram-positive and gram-negative bacteria. The usual dosage for adults is 200–400 mg daily, either as a single dose or divided into two doses. For children over 12 years, the dosage is similar, adjusted based on body weight and the severity of the infection.
Change Language